应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
01558 东阳光长江药业
休市中 07-11 16:08:03
15.060
+0.160
+1.07%
最高
15.240
最低
14.820
成交量
618.00万
今开
14.980
昨收
14.900
日振幅
2.82%
总市值
132.52亿
流通市值
98.49亿
总股本
8.80亿
成交额
9,287万
换手率
0.94%
流通股本
6.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
向全球输出创新，东阳光药有望成为中国创新药新样本
中国网财经 · 07-11 09:31
向全球输出创新，东阳光药有望成为中国创新药新样本
每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股，卖空比例为0.99%
市场透视 · 07-11 08:30
每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股，卖空比例为0.99%
每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股，卖空比例为1.61%
市场透视 · 07-10 08:30
每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股，卖空比例为1.61%
东阳光长江药业07月09日遭主力抛售1012.5万元
市场透视 · 07-09
东阳光长江药业07月09日遭主力抛售1012.5万元
载誉而归，东阳光药发明专利斩获湖北专利金奖
动脉网 · 07-08
载誉而归，东阳光药发明专利斩获湖北专利金奖
每日卖空追踪 | 东阳光长江药业 07月07日卖空量成交17.2万股，卖空比例为3.3%
市场透视 · 07-07
每日卖空追踪 | 东阳光长江药业 07月07日卖空量成交17.2万股，卖空比例为3.3%
东阳光长江药业07月04日遭主力抛售286.1万元
市场透视 · 07-04
东阳光长江药业07月04日遭主力抛售286.1万元
“可威”专利倒计时之下的东阳光药
瀚数财经 · 07-02
“可威”专利倒计时之下的东阳光药
每日卖空追踪 | 东阳光长江药业 07月02日卖空量成交20.78万股，卖空比例为3.05%
市场透视 · 07-02
每日卖空追踪 | 东阳光长江药业 07月02日卖空量成交20.78万股，卖空比例为3.05%
隐藏的代谢巨头，正在崛起
医药魔方 · 07-01
隐藏的代谢巨头，正在崛起
每日卖空追踪 | 东阳光长江药业 06月30日卖空量成交36.1万股，卖空比例为4.5%
市场透视 · 06-30
每日卖空追踪 | 东阳光长江药业 06月30日卖空量成交36.1万股，卖空比例为4.5%
东阳光药成功通过港股聆讯：廿载深耕结硕果，创新出海启新程
证券市场周刊 · 06-27
东阳光药成功通过港股聆讯：廿载深耕结硕果，创新出海启新程
东阳光药申请奈玛特韦或其盐的杂质检测方法专利，灵敏度高
金融界 · 06-27
东阳光药申请奈玛特韦或其盐的杂质检测方法专利，灵敏度高
东阳光长江药业06月27日主力净流出115.4万元 散户资金买入
市场透视 · 06-27
东阳光长江药业06月27日主力净流出115.4万元 散户资金买入
【国药现代：阿奇霉素干混悬剂通过仿制药一致性评价】国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。
金融界 · 06-26
【国药现代：阿奇霉素干混悬剂通过仿制药一致性评价】国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。
东阳光长江药业盘中异动 临近午盘股价大涨5.13%
市场透视 · 06-26
东阳光长江药业盘中异动 临近午盘股价大涨5.13%
每日卖空追踪 | 东阳光长江药业 06月24日卖空量成交17.72万股，卖空比例为4.56%
市场透视 · 06-24
每日卖空追踪 | 东阳光长江药业 06月24日卖空量成交17.72万股，卖空比例为4.56%
东阳光药IPO：收入依赖单一产品，近年来利润大幅波动
面包财经 · 06-23
东阳光药IPO：收入依赖单一产品，近年来利润大幅波动
东阳光长江药业06月23日主力净流出441.7万元 散户资金买入
市场透视 · 06-23
东阳光长江药业06月23日主力净流出441.7万元 散户资金买入
东阳光药业通过IPO备案：年营收40亿 期内利润同比降98%
雷递网 · 06-21
东阳光药业通过IPO备案：年营收40亿 期内利润同比降98%
加载更多
公司概况
公司名称：
东阳光长江药业
所属市场：
SEHK
上市日期：
--
主营业务：
宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。
发行价格：
--
{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":15.06,"timestamp":1752221283027,"preClose":14.9,"halted":0,"volume":6180000,"delay":0,"floatShares":654000000,"shares":879967700,"eps":0.6002453881453456,"marketStatus":"休市中","change":0.16,"latestTime":"07-11 16:08:03","open":14.98,"high":15.24,"low":14.82,"amount":92865012,"amplitude":0.028188,"askPrice":15.06,"askSize":508200,"bidPrice":15.04,"bidSize":5600,"shortable":3,"etf":0,"ttmEps":0.6002453881453456,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":7,"adr":0,"listingDate":1451318400000,"exchange":"SEHK","adjPreClose":14.9,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":1.1328234381513909,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01558","defaultTab":"news","newsList":[{"id":"2550939452","title":"向全球输出创新，东阳光药有望成为中国创新药新样本","url":"https://stock-news.laohu8.com/highlight/detail?id=2550939452","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550939452?lang=zh_cn&edition=full","pubTime":"2025-07-11 17:31","pubTimestamp":1752226265,"startTime":"0","endTime":"0","summary":"截至目前，东阳光药拥有：全球150款获批药物；超过100款在研药物；中国市场3款1类创新药上市、1款1类创新药申请上市……同时，东阳光药也是鲜有能够递交美国FDA申请，且有望成为首家可豁免3期临床试验而在美国上市甘精胰岛素类似药的企业。上述业内人士指出，当中国药企普遍面临价格内卷、创新乏力、融资受限、国际化受阻等瓶颈时，老牌药企东阳光药率先实现转型，向全球反向输出创新，有望成为中国创新药新样本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173602a44486b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173602a44486b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1515","01558","BK1161","06978"],"gpt_icon":0},{"id":"2550455939","title":"每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股，卖空比例为0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550455939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550455939?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222623,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月11日，涨1.07%，卖空量成交6.1万股%，较上一交易日减少68.62%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172322a4447efe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172322a4447efe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2550610185","title":"每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股，卖空比例为1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550610185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550610185?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:30","pubTimestamp":1752136222,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月10日，涨3.62%，卖空量成交11.1万股%，较上一交易日减少50.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171919a6a1474b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171919a6a1474b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2550568097","title":"东阳光长江药业07月09日遭主力抛售1012.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550568097","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550568097?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:15","pubTimestamp":1752048951,"startTime":"0","endTime":"0","summary":"07月09日, 东阳光长江药业股价跌2.04%，报收14.38元，成交金额6261.8万元，换手率0.66%，振幅3.54%，量比0.75。东阳光长江药业今日主力资金净流出1012.5万元，上一交易日主力净流出605.8万元。该股近5个交易日下跌4.01%，主力资金累计净流出1763.9万元；近20日主力资金累计净流出2161.1万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170356a43ff74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709170356a43ff74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2549493365","title":"载誉而归，东阳光药发明专利斩获湖北专利金奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2549493365","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549493365?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:42","pubTimestamp":1751971320,"startTime":"0","endTime":"0","summary":"东阳光药发明专利荣获第二届湖北专利金奖，其研发的丙肝创新药磷酸依米他韦经十年努力成功上市，治愈率高达99.8%，已纳入国家医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708185924953abd53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708185924953abd53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01558","06978","BK1515","BK1161"],"gpt_icon":0},{"id":"2549587243","title":"每日卖空追踪 | 东阳光长江药业 07月07日卖空量成交17.2万股，卖空比例为3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549587243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549587243?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:30","pubTimestamp":1751877023,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月07日，涨1.93%，卖空量成交17.2万股%，较上一交易日增加27.98%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171753a69aa965&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707171753a69aa965&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2548361331","title":"东阳光长江药业07月04日遭主力抛售286.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548361331","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548361331?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:15","pubTimestamp":1751616953,"startTime":"0","endTime":"0","summary":"07月04日, 东阳光长江药业股价跌0.41%，报收14.50元，成交金额1.1亿元，换手率1.19%，振幅4.53%，量比0.93。东阳光长江药业今日主力资金净流出286.1万元，连续5日净流出，上一交易日主力净流出846.2万元。该股近5个交易日下跌3.07%，主力资金累计净流出3938.3万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出9548.5万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704170535a72e7ef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704170535a72e7ef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2548816017","title":"“可威”专利倒计时之下的东阳光药","url":"https://stock-news.laohu8.com/highlight/detail?id=2548816017","media":"瀚数财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548816017?lang=zh_cn&edition=full","pubTime":"2025-07-02 20:33","pubTimestamp":1751459593,"startTime":"0","endTime":"0","summary":"“可威”之后，东阳光药还有牌可打吗？2024年，“可威”颗粒剂型的收入为21.82亿元，占东阳光长江药业总收入的比重达58.59%，胶囊剂型收入为3.07亿元，占比8.24%，两大剂型的”可威”合计在东阳光长江药业收入中的占比高达66.84%，对东阳光药总收入的贡献比例则达到64.2%。在奥司他韦化合物专利2017年到期、“可威”合成工艺专利2024年3月到期之后，“可威”颗粒剂型的相关专利也将在不远的2026年4月到期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702205833a4cb448e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702205833a4cb448e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":1},{"id":"2548867570","title":"每日卖空追踪 | 东阳光长江药业 07月02日卖空量成交20.78万股，卖空比例为3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867570?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:30","pubTimestamp":1751445024,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月02日，涨0.94%，卖空量成交20.78万股%，较上一交易日减少52.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171937a72a481d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702171937a72a481d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2548836091","title":"隐藏的代谢巨头，正在崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2548836091","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548836091?lang=zh_cn&edition=full","pubTime":"2025-07-02 07:58","pubTimestamp":1751414325,"startTime":"0","endTime":"0","summary":"而在众多参与者之中，一个隐藏的代谢巨头正在崛起——东阳光药正以GLP-1多靶点激动剂为关键锚点，构建起跨越糖尿病、肥胖、NASH的庞大代谢版图，开辟出了自己的突围路径。因此，HEC-007具有良好的成药性，有望为肥胖患者带来新的治疗方案。与目前已上市的GLP-1受体激动剂相比，GLP-1/FGF21双靶点激动剂在降糖、减重及有效缓解NASH方面上均具有优势。目前，东阳光药正在中国进行针对2型糖尿病适应症的II期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702080642a7293f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702080642a7293f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2547006236","title":"每日卖空追踪 | 东阳光长江药业 06月30日卖空量成交36.1万股，卖空比例为4.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547006236","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547006236?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:30","pubTimestamp":1751272221,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间06月30日，跌0.4%，卖空量成交36.1万股%，较上一交易日增加27.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171745a725c35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630171745a725c35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2546458697","title":"东阳光药成功通过港股聆讯：廿载深耕结硕果，创新出海启新程","url":"https://stock-news.laohu8.com/highlight/detail?id=2546458697","media":"证券市场周刊","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546458697?lang=zh_cn&edition=full","pubTime":"2025-06-27 20:07","pubTimestamp":1751026020,"startTime":"0","endTime":"0","summary":"东阳光集团旗下核心医药平台——东阳光药成功通过香港联合交易所聆讯，即将实现东阳光药业板块一体化。这不仅是东阳光药发展历程中的重要里程碑，更是东阳光集团二十余载矢志不渝深耕医药健康产业，以创新为引擎驱动发展的辉煌见证。廿载坚守，厚植医药创新沃土。站在国际资本市场的新起点，东阳光药将始终铭记“为国家、为人民做好药”的崇高使命。东阳光药的成功聆讯，是过往辉煌的总结，更是崭新篇章的开启。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627201211952e17a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627201211952e17a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK0070","BK0012","BK0188","600673","BK0028","BK0003","BK0265"],"gpt_icon":0},{"id":"2546715576","title":"东阳光药申请奈玛特韦或其盐的杂质检测方法专利，灵敏度高","url":"https://stock-news.laohu8.com/highlight/detail?id=2546715576","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546715576?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:50","pubTimestamp":1751014211,"startTime":"0","endTime":"0","summary":"金融界2025年6月27日消息，国家知识产权局信息显示，广东东阳光药业股份有限公司申请一项名为“一种奈玛特韦或其盐的杂质的检测方法”的专利，公开号CN120214123A，申请日期为2023年12月。专利摘要显示，本发明提供一种奈玛特韦或其盐的杂质的检测方法，属于药物分析领域。通过天眼查大数据分析，广东东阳光药业股份有限公司共对外投资了10家企业，参与招投标项目5000次，财产线索方面有商标信息13条，专利信息1289条，此外企业还拥有行政许可168个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627165743a720757f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627165743a720757f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2546711253","title":"东阳光长江药业06月27日主力净流出115.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2546711253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546711253?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:15","pubTimestamp":1751012157,"startTime":"0","endTime":"0","summary":"06月27日, 东阳光长江药业股价跌0.67%，报收14.90元，成交金额9990.5万元，换手率1.02%，振幅3.60%，量比0.94。东阳光长江药业今日主力资金净流出115.4万元，上一交易日主力净流入2663.4万元。该股近5个交易日上涨6.43%，主力资金累计净流入2386.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出7455.1万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627173504a7208f45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627173504a7208f45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2546782511","title":"【国药现代：阿奇霉素干混悬剂通过仿制药一致性评价】国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546782511","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546782511?lang=zh_cn&edition=full","pubTime":"2025-06-26 19:08","pubTimestamp":1750936139,"startTime":"0","endTime":"0","summary":"国药现代公告，公司阿奇霉素干混悬剂通过仿制药质量和疗效一致性评价。阿奇霉素干混悬剂2024年全国公立医疗机构及城市药店销售额为14.75亿元。目前通过一致性评价的企业包括石药集团欧意药业有限公司、宜昌东阳光长江药业股份有限公司、苏州东瑞制药有限公司、海南普利制药股份有限公司等。公司累计研发投入约1737.25万元。本次通过一致性评价有利于产品市场拓展和销售，但业绩影响存在不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26190851327499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1008478684.HKD","LU0501845795.SGD","SG9999004220.SGD","BK1574","BK1191","IE0008368742.USD","BK0082","BK0010","LU1152091168.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","BK0132","LU1993786604.SGD","LU0140636845.USD","LU1807302812.USD","LU1226288170.HKD","LU1226287792.SGD","01558","IE00B5MMRT66.SGD","600420","IE00B543WZ88.USD","02348","BK0239","LU1960683339.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE0008369823.USD","LU1226288253.USD","LU1152091754.HKD","BK1515","IE00B031HY20.USD","LU0072913022.USD","LU0067412154.USD","BK0020","01093","LU1951186391.HKD","LU1226287529.USD","BK1521","LU1226287875.USD","01477","LU0326950275.SGD"],"gpt_icon":0},{"id":"2546426274","title":"东阳光长江药业盘中异动 临近午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546426274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546426274?lang=zh_cn&edition=full","pubTime":"2025-06-26 11:36","pubTimestamp":1750909008,"startTime":"0","endTime":"0","summary":"2025年06月26日临近午盘11时36分，东阳光长江药业股票出现异动，股价大幅上涨5.13%。东阳光长江药业股票所在的药品行业中，整体跌幅为0.92%。其相关个股中，君圣泰医药-B、东阳光长江药业、培力农本方涨幅较大，振幅较大的相关个股有精优药业、君圣泰医药-B、德琪医药-B，振幅分别为21.18%、13.85%、10.03%。东阳光长江药业公司简介：宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626113650a4be68ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626113650a4be68ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2545288081","title":"每日卖空追踪 | 东阳光长江药业 06月24日卖空量成交17.72万股，卖空比例为4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545288081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545288081?lang=zh_cn&edition=full","pubTime":"2025-06-24 16:30","pubTimestamp":1750753821,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间06月24日，涨1.29%，卖空量成交17.72万股%，较上一交易日减少50.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624174340a71afe3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624174340a71afe3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2545949608","title":"东阳光药IPO：收入依赖单一产品，近年来利润大幅波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2545949608","media":"面包财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545949608?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:42","pubTimestamp":1750668120,"startTime":"0","endTime":"0","summary":"对于2024年磷酸奥司他韦销售额下降原因，公司表示主要系2024年中国的季节性流感的发病率较2023年减少，引致可威颗粒及胶囊销售额下跌。慢病治疗药物方面，2024年收入为10.68亿元，总营收占比26.6%，同比上升17.5个百分点。公司截至最后实际可行日期，在不同国家及地区拥有150款获批药物，于中国及境外市场分别销售48种及23种药品。2023年，核心产品可威市场需求的旺盛，到了2024年季节性流感发病率下跌，使得以可威为代表的抗感染药物销售收入锐减。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623164326978b02f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623164326978b02f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2545926914","title":"东阳光长江药业06月23日主力净流出441.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2545926914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545926914?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:15","pubTimestamp":1750666547,"startTime":"0","endTime":"0","summary":"06月23日, 东阳光长江药业股价跌0.43%，报收13.94元，成交金额8921.2万元，换手率0.99%，振幅4.57%，量比0.85。东阳光长江药业今日主力资金净流出441.7万元，上一交易日主力净流入96.3万元。该股近5个交易日下跌5.83%，主力资金累计净流出1740.0万元；近20日主力资金累计净流出1.2亿元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623172325a4b89dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623172325a4b89dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2545489432","title":"东阳光药业通过IPO备案：年营收40亿 期内利润同比降98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545489432","media":"雷递网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545489432?lang=zh_cn&edition=full","pubTime":"2025-06-21 22:38","pubTimestamp":1750516727,"startTime":"0","endTime":"0","summary":"东阳光药业于中国及境外市场销售48种及23种药品。东阳光药业主要产品的销售额分别占截至2022年、2023年及2024年12月31日止年度总收入的92.6%、95.3%及84.9%。东阳光药业2024年来自抗感染药物的收入为28亿元，占营收的比例为69.6%；来自慢病治疗药物的收入为10.68亿元，占比为26.6%。东阳光药业2024年营收同比下降37%；经营利润同比下降78.4%；期内利润同比下降97.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506212239379525e57d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506212239379525e57d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":0.0386},{"period":"1month","weight":0.0788},{"period":"3month","weight":0.4481},{"period":"6month","weight":0.5639},{"period":"1year","weight":0.6979},{"period":"ytd","weight":0.5753}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.043067},{"month":2,"riseRate":0.8,"avgChangeRate":0.085582},{"month":3,"riseRate":0.4,"avgChangeRate":-0.060003},{"month":4,"riseRate":0.7,"avgChangeRate":0.045268},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005154},{"month":6,"riseRate":0.7,"avgChangeRate":0.069784},{"month":7,"riseRate":0.5,"avgChangeRate":-0.048864},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.04223},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045743},{"month":10,"riseRate":0.444444,"avgChangeRate":0.024617},{"month":11,"riseRate":0.777778,"avgChangeRate":0.132165},{"month":12,"riseRate":0.555556,"avgChangeRate":0.011051}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}